title: Cancer of the prostate. Mechanisms of action of antiandrogens.
authors.affiliation: N.V. Schering S.A., Diegem.
authors.forename: U F
authors.initials: UF
authors.lastname: Habenicht
authors.forename: F
authors.initials: F
authors.lastname: Neumann
authors.forename: M F
authors.initials: MF
authors.lastname: el Etreby
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D000818:Animals; D003534:Cyproterone / Q000031:analogs & derivatives / Q000494:pharmacology; D017373:Cyproterone Acetate; D004359:Drug Therapy, Combination; D005485:Flutamide / Q000494:pharmacology; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors; D006801:Humans; D007986:Luteinizing Hormone / Q000378:metabolism; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D051381:Rats; D013739:Testosterone / Q000378:metabolism
chemical_list: D000726:Androgen Antagonists; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D017373:Cyproterone Acetate; D005485:Flutamide; D007986:Luteinizing Hormone; D003534:Cyproterone